DCF — CEDARS-SINAI MEDICAL CENTER
Enterprise Value: $-3.8B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-3.8B
Enterprise Value
$-1.2B
PV of Cash Flows
$-2.5B
PV of Terminal Value
$-4.0B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $4.0B | $-202.8M | -5.0% | $-373.9M | $-339.9M |
| Year 2 | $4.2B | $-167.3M | -4.0% | $-343.5M | $-283.9M |
| Year 3 | $4.3B | $-129.5M | -3.0% | $-310.9M | $-233.6M |
| Year 4 | $4.4B | $-111.3M | -3.0% | $-298.2M | $-203.6M |
| Year 5 | $4.5B | $-103.2M | -2.0% | $-295.7M | $-183.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-3.8B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$3.9B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0552018607945106
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5